Feature | Heart Failure | March 09, 2022

David Bennett, Pig Heart Transplant Patient, Dies

57-year-old Maryland resident David Bennett, the first human to receive a pig heart transplant, has passed away

The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yesterday afternoon on March 8.

Image courtesy of The University of Maryland Medical Center


The University of Maryland Medical Center has announced that David Bennett, the 57-year old patient with terminal heart disease who made history as the first person to receive a genetically modified pig’s heart, passed away yesterday afternoon on March 8. Bennett received the transplant on January 7 and lived for two months following the surgery. His condition began deteriorating several days ago. After it became clear that he would not recover, he was given compassionate palliative care. He was able to communicate with his family during his final hours.

“We are devastated by the loss of Mr. Bennett. He proved to be a brave and noble patient who fought all the way to the end. We extend our sincerest condolences to his family,” said Bartley P. Griffith, MD, who surgically transplanted the pig heart into the patient at the University of Maryland Medical Center (UMMC). Griffith is the Thomas E. and Alice Marie Hales Distinguished Professor in Transplant Surgery and Clinical Director of the Cardiac Xenotransplantation Program at the University of Maryland School of Medicine (UMSOM). “Mr. Bennett became known by millions of people around the world for his courage and steadfast will to live.”

Muhammad M. Mohiuddin, MD, Professor of Surgery and Scientific Director of the Cardiac Xenotransplantation Program at UMSOM, added: “We are grateful to Mr. Bennett for his unique and historic role in helping to contribute to a vast array of knowledge to the field of xenotransplantation.”

Bennett first came to UMMC as a patient in October 2021, where he was bedridden and placed on a heart-lung bypass machine, called extracorporeal membrane oxygenation (ECMO), to remain alive. He was deemed ineligible for a conventional heart transplant. Before consenting to receive the transplant, Bennett was fully informed of the procedure’s risks, and that the procedure was experimental with unknown risks and benefits. On December 31, the US Food and Drug Administration granted an emergency authorization for the surgery in the hope of saving his life.

Following surgery, the transplanted heart performed very well for several weeks without any signs of rejection. The patient was able to spend time with his family and participate in physical therapy to help regain strength. He watched the Super Bowl with his physical therapist and spoke often about wanting to get home to his dog Lucky.

“We have gained invaluable insights learning that the genetically modified pig heart can function well within the human body while the immune system is adequately suppressed,” said Mohiuddin. “We remain optimistic and plan on continuing our work in future clinical trials.”

Added Griffith: “As with any first-in-the-world transplant surgery, this one led to valuable insights that will hopefully inform transplant surgeons to improve outcomes and potentially provide lifesaving benefits to future patients.”

For more information: www.umms.org

Related Heart Transplant News:

Pig Heart Transplant Patient Continues to Thrive

First Human Receives a Pig Heart Transplant

Transplanting Pig Hearts Into Humans One Step Closer

FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

Heart in a Box Technology Expands Heart Transplant Window

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’s Breakthrough Device Designation

FDA Clears SynCardia 50cc Temporary Total Artificial Heart as Bridge to Transplant

Stephanie’s Heart: The Story of Baby Fae

Hearts from donors who used illicit drugs or overdosed safe for transplant, cuts wait time

National Trends in Heart Donor Utilization Rates: Are We Efficiently Transplanting More Hearts?

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage

Find more cardiac surgery technology content

Find more heart failure technology content


Related Content

News | Heart Failure

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

Home June 27, 2024
Home
News | Heart Failure

June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...

Home June 24, 2024
Home
News | Heart Failure

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
News | Heart Failure

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million ...

Home June 07, 2024
Home
News | Heart Failure

June 7, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home June 07, 2024
Home
News | Heart Failure

May 28, 2024 — Yoga focused on breathing, meditation, and relaxation is linked with symptom improvement in patients with ...

Home May 28, 2024
Home
News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
Subscribe Now